Developing evidence-based guidelines for management of alimentary mucositis: process and pitfalls

Area of Science:

• Oncology
• Evidence-Based Medicine
• Clinical Practice Guidelines

Background:

• Clinical oncology practice requires continuous updates due to new technologies and treatments.
• Multidisciplinary care teams and evidence-based protocols are increasingly vital.
• Developing and maintaining current clinical guidelines is challenging but essential.

Purpose of the Study:

• To describe the process and lessons learned in developing evidence-based guidelines for mucositis management.
• To highlight the importance of education, evaluation, and timely updates in guideline development.
• To provide a framework for other groups undertaking similar guideline projects.

Main Methods:

• Expert teams reviewed literature to create management guidelines and protocols.
• Focus shifted towards supportive oncology, including guidelines for neutropenic fever, antiemetics, and mucositis.
• The Mucositis Study Group (MSG) was formed to address mucosal injury in cancer patients.

Main Results:

• Evidence-based guidelines for mucositis management were developed by the MSG.
• Original guidelines published in 2004, with updated versions following.
• Companion papers discussed the scientific basis of mucositis.

Conclusions:

• The process of guideline development involves collaboration and rigorous review.
• Lessons learned can assist other organizations in creating similar clinical guidelines.
• Effective guidelines require broad awareness, clinical utility, and alignment with current research.